These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9683542)

  • 1. Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments.
    Gillard BK; Clement R; Colucci-Guyon E; Babinet C; Schwarzmann G; Taki T; Kasama T; Marcus DM
    Exp Cell Res; 1998 Aug; 242(2):561-72. PubMed ID: 9683542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of glycosphingolipid biosynthesis in SW13 cells in the presence and absence of vimentin intermediate filaments.
    Gillard BK; Harrell RG; Marcus DM
    Glycobiology; 1996 Jan; 6(1):33-42. PubMed ID: 8991507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells.
    Gillard BK; Thurmon LT; Marcus DM
    Cell Motil Cytoskeleton; 1992; 21(4):255-71. PubMed ID: 1628323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of glycosphingolipids is reduced in the absence of a vimentin intermediate filament network.
    Gillard BK; Thurmon LT; Harrell RG; Capetanaki Y; Saito M; Yu RK; Marcus DM
    J Cell Sci; 1994 Dec; 107 ( Pt 12)():3545-55. PubMed ID: 7706405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperacidification of trans-Golgi network and endo/lysosomes in melanocytes by glucosylceramide-dependent V-ATPase activity.
    van der Poel S; Wolthoorn J; van den Heuvel D; Egmond M; Groux-Degroote S; Neumann S; Gerritsen H; van Meer G; Sprong H
    Traffic; 2011 Nov; 12(11):1634-47. PubMed ID: 21810155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vimentin and lipid metabolism.
    Schweitzer SC; Evans RM
    Subcell Biochem; 1998; 31():437-62. PubMed ID: 9932502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and degradation of mammalian glycosphingolipids.
    Sandhoff K; Kolter T
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):847-61. PubMed ID: 12803917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways.
    Gillard BK; Clement RG; Marcus DM
    Glycobiology; 1998 Sep; 8(9):885-90. PubMed ID: 9675221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments.
    Toivola DM; Tao GZ; Habtezion A; Liao J; Omary MB
    Trends Cell Biol; 2005 Nov; 15(11):608-17. PubMed ID: 16202602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo synthesis of type 1 lacto-series glycolipids in human colonic adenocarcinoma cells: efficient synthesis of the Le(a) antigen and absence of brefeldin A-induced inhibition of its synthesis in Colo 205 cells.
    Holmes EH; Greene TG
    Arch Biochem Biophys; 1993 Sep; 305(2):328-40. PubMed ID: 8373171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin.
    Geerts A; Eliasson C; Niki T; Wielant A; Vaeyens F; Pekny M
    Hepatology; 2001 Jan; 33(1):177-88. PubMed ID: 11124834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent analogues of plasma membrane sphingolipids are sorted to different intracellular compartments in astrocytes; Harmful effects of chronic ethanol exposure on sphingolipid trafficking and metabolism.
    Tomás M; Durán JM; Lázaro-Diéguez F; Babià T; Renau-Piqueras J; Egea G
    FEBS Lett; 2004 Apr; 563(1-3):59-65. PubMed ID: 15063723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular biology of glycosphingolipid glycosylation.
    Maccioni HJ; Quiroga R; Ferrari ML
    J Neurochem; 2011 May; 117(4):589-602. PubMed ID: 21371037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate and function of glycosphingolipid glucosylceramide.
    van Meer G; Wolthoorn J; Degroote S
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):869-73. PubMed ID: 12803919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1a and CD1b surface expression is independent from de novo synthesized glycosphingolipids.
    Manolova V; Hirabayashi Y; Mori L; De Libero G
    Eur J Immunol; 2003 Jan; 33(1):29-37. PubMed ID: 12594829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible rearrangement of vimentin-type intermediate filaments in cultured human skin fibroblasts from patients with lysosomal storage diseases.
    Tatiana I; German W
    Cell Biol Int; 1994 Jun; 18(6):647-53. PubMed ID: 8075625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vimentin: the conundrum of the intermediate filament gene family.
    Evans RM
    Bioessays; 1998 Jan; 20(1):79-86. PubMed ID: 9504050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside/glycosphingolipid turnover: new concepts.
    Tettamanti G
    Glycoconj J; 2004; 20(5):301-17. PubMed ID: 15229395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fingerprinting taste buds: intermediate filaments and their implication for taste bud formation.
    Witt M; Reutter K; Ganchrow D; Ganchrow JR
    Philos Trans R Soc Lond B Biol Sci; 2000 Sep; 355(1401):1233-7. PubMed ID: 11079405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.